{"id":"W2100409734","doi":"10.1016/s0140-6736(08)61236-2","title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1588,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Ramipril; Telmisartan; Medicine; Renal function; Creatinine; Urology; Proteinuria; Internal medicine; Dialysis; Hazard ratio; Combination therapy; ACE inhibitor; Angiotensin-converting enzyme; Kidney; Blood pressure; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}